Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using tDCS in Speech-based Stroke Rehabilitation

NCT03452202 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03452202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using tDCS in Speech-based Stroke Rehabilitation
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Recruiting
Start date
January 11, 2019
Completion date
April 30, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

apraxia of speech